Fallbericht
Long term response to immunotherapy in a patient with low PD-L1 expression, high tumor mutational burden, and STK11 mutation
Klinicka onkologie · 2026
DOI: 10.48095/ccko2026364 ↗Kurz gefasst
Fallbericht in der Zeitschrift Klinicka onkologie, 2026. Verfasst von Michal Kysela und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Lung Neoplasms, B7-H1 Antigen, Immunotherapy, Protein Serine-Threonine Kinases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Lung NeoplasmsB7-H1 AntigenImmunotherapyProtein Serine-Threonine KinasesAdenocarcinoma of LungCarcinoma, Non-Small-Cell LungHumansAMP-Activated Protein Kinase KinasesMutationAntibodies, Monoclonal, HumanizedImmune Checkpoint InhibitorsMale
Stichwörter der Autor:innen
Non-small cell lung cancerSTK11immunotherapyimmunotherapynon-small cell lung cancertumor mutational burden
Substanzen
STK11 protein, humanAMP-Activated Protein Kinase KinasesB7-H1 AntigenProtein Serine-Threonine KinasesCD274 protein, humanAntibodies, Monoclonal, HumanizedpembrolizumabImmune Checkpoint Inhibitors
Zitieren
APA
Kysela, M., Bílek, O., Obermannová, R. L., & Grell, P. (2026). Long term response to immunotherapy in a patient with low PD-L1 expression, high tumor mutational burden, and STK11 mutation. Klinicka onkologie. https://doi.org/10.48095/ccko2026364
Vancouver
Kysela M, Bílek O, Obermannová RL, Grell P. Long term response to immunotherapy in a patient with low PD-L1 expression, high tumor mutational burden, and STK11 mutation. Klinicka onkologie. 2026. doi:10.48095/ccko2026364
BibTeX
@article{Kysela2026,
author = {Kysela, Michal and Bílek, Ondřej and Obermannová, Radka Lordick and Grell, Peter},
title = {Long term response to immunotherapy in a patient with low PD-L1 expression, high tumor mutational burden, and STK11 mutation},
journal = {Klinicka onkologie},
year = {2026},
doi = {10.48095/ccko2026364}
}
EUVIMED